𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Simultaneous determination of plasma and urinary carcinoembryonic antigen levels

✍ Scribed by C. P. Karakousis; E. D. Holyoke; T. M. Chu


Book ID
102438475
Publisher
John Wiley and Sons
Year
1975
Tongue
English
Weight
257 KB
Volume
7
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The results of simultaneous plasma and urinary CEA levels in 14 patients are described. The aim was to determine whether urinary CEA derived from plasma or arose independently in the urinary tract. The method of reductio ad absurdum is followed. It is assumed that CEA in the urine is derived from plasma, and CEA clearance values for each patient are calculated. These varied widely from zero to a theoretical infinity. On this basis and from previous experimental evidence, it is concluded that urine is independent of plasma CEA. The finding, however, in some individuals of β€œanti‐CEA” ‐like factor(s) distorting urinary CEA determinations makes for some reservations about the safety of the conclusion. It is, however, certain that with the presently available technology, present urinary and plasma CEA values cannot be correlated.


πŸ“œ SIMILAR VOLUMES


Marked elevation of plasma carcinoembryo
✍ Yutaka Horie; Kunihiko Miura; Katsuaki Matsui; Akira Yukimasa; Shinji Ohi; Tetsu πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 531 KB

This study was undertaken to clarify the relationship between marked elevation of plasma carcinoembryonic antigen (CM) and signet ring cell carcinoma of the stomach. METHODS. To elucidate the contributing factor of extreme elevation of plasma CEA value, the histologic and biochemical records for 3 1

Simultaneous Determination of Ξ±-Fetoprot
✍ Kazuko Matsumoto; Jingli Yuan; Guilan Wang; Hiroko Kimura πŸ“‚ Article πŸ“… 1999 πŸ› Elsevier Science 🌐 English βš– 105 KB

A novel simultaneous measurement method for ␣-fetoprotein (AFP) and carcinoembryonic antigen (CEA) in human sera by time-resolved fluoroimmunoassay (TR-FIA) is described. The proposed approach combines the use of europium-labeled anti-AFP antibody for AFP TR-FIA and biotinylated anti-CEA antibody co